(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Tractor Supply Company TSCO, Merck MRK and others.

Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.

Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.

Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.

In the next session, Via News will report the finding on the algorithm precision.

Financial Asset Accuracy Close Price Prediction
Tractor Supply Company (TSCO) 94.27% $225.76 $230.33
Merck (MRK) 94.14% $106.82 $109.96
Ulta Beauty (ULTA) 93.94% $447.37 $448.77
Dropbox (DBX) 93.76% $22.44 $22.76
Consolidated Edison (ED) 93.73% $96.67 $98.53
Interactive Brokers Group (IBKR) 93.59% $78.16 $80.21
Bristol (BMY) 93.42% $79.14 $81.44
Gilead Sciences (GILD) 93.4% $85.42 $87.31
The Travelers Companies (TRV) 93.08% $188.01 $192.86
Fifth Third Bancorp (FITBI) 89.58% $25.63 $25.75
AbbVie (ABBV) 89.4% $159.39 $162.15
Zoetis (ZTS) 89.32% $150.47 $152.05
Chubb Corporation (CB) 89.26% $214.15 $217.91
Cardinal Health (CAH) 89.25% $78.44 $79.25
Astrazeneca (AZN) 89.16% $66.12 $67.09
Broadridge Financial Solutions (BR) 89.13% $148.43 $151.87
Nasdaq Inc (NDAQ) 89.11% $67.13 $68.31
Rogers Communication (RCI) 88.95% $45.02 $45.78
Waste Connections (WCN) 88.87% $141.98 $144.79
TJX Companies (TJX) 88.84% $80.54 $81.98
Johnson & Johnson (JNJ) 88.67% $177.01 $180.67
Royalty Pharma (RPRX) 88.67% $42.93 $43.26
Sempra Energy (SRE) 88.65% $163 $166.81
NewMarket (NEU) 88.42% $314.7 $322.85
Etsy (ETSY) 88.24% $119.99 $123.77
Horizon Therapeutics (HZNP) 88.13% $77.53 $79.23
Bank of New York Mellon (BK) 87.92% $45.49 $46.82
Southwestern Energy (SWN) 87.87% $7.22 $7.16
Super Micro Computer (SMCI) 87.64% $91.22 $92.94
Zebra Technologies (ZBRA) 87.39% $270.66 $280.59

1. Tractor Supply Company (TSCO)

Shares of Tractor Supply Company rose 4.2% in from $216.66 to $225.76 at 18:21 EST on Thursday, after four consecutive sessions in a row of gains. NASDAQ is rising 0.99% to $11,285.32, after two successive sessions in a row of gains.

Tractor Supply Company operates as a rural lifestyle retailer in the United States. The company offers a selection of merchandise, including equine, livestock, pet, and small animal products necessary for their health, care, growth, and containment; hardware, truck, towing, and tool products; seasonal products, such as heating products, lawn and garden items, power equipment, gifts, and toys; work/recreational clothing and footwear; and maintenance products for agricultural and rural use. It provides its products under the 4health, Producer's Pride, American Farmworks, Red Shed, Bit & Bridle, Redstone, Blue Mountain, Retriever, C.E. Schmidt, Ridgecut, Countyline, Royal Wing, Dumor, Strive, Groundwork, Traveller, Huskee, Treeline, JobSmart, TSC Tractor Supply Co, Paws & Claws, and Untamed brands. As of June 25, 2022, it operated 2,016 Tractor Supply stores in 49 states; and 178 Petsense stores in 23 states. The company operates its retail stores under the Tractor Supply Company, Del's Feed & Farm Supply, and Petsense names; and operates websites under the TractorSupply.com and Petsense.com names. It sells its products to recreational farmers, ranchers, and others. The company was founded in 1938 and is based in Brentwood, Tennessee.

Volatility

Tractor Supply Company’s last week, last month’s, and last quarter’s current intraday variation average was 0.49%, 0.45%, and 1.66%.

Tractor Supply Company’s highest amplitude of average volatility was 1.47% (last week), 1.76% (last month), and 1.66% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 13.52B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Tractor Supply Company’s stock is considered to be oversold (<=20).

More news about Tractor Supply Company.

2. Merck (MRK)

Shares of Merck jumped 8.34% in from $98.6 to $106.82 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is rising 0.41% to $15,545.52, after two consecutive sessions in a row of gains.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Volatility

Merck’s last week, last month’s, and last quarter’s current intraday variation average was 1.53%, 0.43%, and 1.13%.

Merck’s highest amplitude of average volatility was 1.53% (last week), 1.15% (last month), and 1.13% (last quarter).

Yearly Top and Bottom Value

Merck’s stock is valued at $106.82 at 18:21 EST, higher than its 52-week high of $104.60.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Merck’s stock is considered to be oversold (<=20).

More news about Merck.

3. Ulta Beauty (ULTA)

Shares of Ulta Beauty rose by a staggering 11.73% in from $400.4 to $447.37 at 18:21 EST on Thursday, following the last session’s downward trend. NASDAQ is rising 0.99% to $11,285.32, after two sequential sessions in a row of gains.

Ulta Beauty, Inc. operates as a retailer of beauty products in the United States. The company's stores offer cosmetics, fragrances, skincare and haircare products, bath and body products, and salon styling tools; professional hair products; salon services, including hair, skin, makeup, and brow services; and nail services. It also provides its private label products, such as the Ulta Beauty Collection branded cosmetics, skincare, and bath products, as well as Ulta Beauty branded products; and the Ulta Beauty branded gifts. As of March 10, 2022, the company operated 1,308 retail stores across 50 states. It also distributes its products through its website ulta.com; and mobile applications. The company was formerly known as Ulta Salon, Cosmetics & Fragrance, Inc. and changed its name to Ulta Beauty, Inc. in January 2017. Ulta Beauty, Inc. was incorporated in 1990 and is based in Bolingbrook, Illinois.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is 3.8% and a drop 3.9% for the next.

More news about Ulta Beauty.

4. Dropbox (DBX)

Shares of Dropbox jumped 3.84% in from $21.61 to $22.44 at 18:21 EST on Thursday, following the last session’s upward trend. NASDAQ is jumping 0.99% to $11,285.32, after two successive sessions in a row of gains.

Dropbox, Inc. provides a content collaboration platform worldwide. Its platform allows individuals, families, teams, and organizations to collaborate and sign up for free through its website or app, as well as upgrade to a paid subscription plan for premium features. As of December 31, 2021, the company had approximately 700 million registered users. It serves customers in professional services, technology, media, education, industrial, consumer and retail, and financial services industries. The company was formerly known as Evenflow, Inc. and changed its name to Dropbox, Inc. in October 2009. Dropbox, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 4.9% and positive 2.6% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 2.25B for the twelve trailing months.

More news about Dropbox.

5. Consolidated Edison (ED)

Shares of Consolidated Edison rose by a staggering 12.83% in from $85.68 to $96.67 at 18:21 EST on Thursday, after five consecutive sessions in a row of gains. NYSE is rising 0.41% to $15,545.52, after two sequential sessions in a row of gains.

Consolidated Edison, Inc., through its subsidiaries, engages in the regulated electric, gas, and steam delivery businesses in the United States. It offers electric services to approximately 3.5 million customers in New York City and Westchester County; gas to approximately 1.1 million customers in Manhattan, the Bronx, parts of Queens, and Westchester County; and steam to approximately 1,555 customers in parts of Manhattan. The company also supplies electricity to approximately 0.3 million customers in southeastern New York and northern New Jersey; and gas to approximately 0.1 million customers in southeastern New York. In addition, it operates 533 circuit miles of transmission lines; 15 transmission substations; 64 distribution substations; 87,564 in-service line transformers; 3,924 pole miles of overhead distribution lines; and 2,291 miles of underground distribution lines, as well as 4,350 miles of mains and 377,971 service lines for natural gas distribution. Further, the company owns, operates, and develops renewable and energy infrastructure projects; and provides energy-related products and services to wholesale and retail customers, as well as invests in electric and gas transmission projects. It primarily sells electricity to industrial, commercial, residential, and government customers. The company was founded in 1823 and is based in New York, New York.

Sales Growth

Consolidated Edison’s sales growth is 4.8% for the present quarter and 3% for the next.

More news about Consolidated Edison.

6. Interactive Brokers Group (IBKR)

Shares of Interactive Brokers Group fell 0.37% in from $78.45 to $78.16 at 18:21 EST on Thursday, after five successive sessions in a row of gains. NASDAQ is jumping 0.99% to $11,285.32, after two consecutive sessions in a row of gains.

Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide. The company specializes in executing, clearing, and settling trades in stocks, options, futures, foreign exchange instruments, bonds, mutual funds, exchange traded funds (ETFs), metals, and cryptocurrencies. It also custodies and services accounts for hedge and mutual funds, ETFs, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. In addition, it offers custody, prime brokerage, securities, and margin lending services. The company serves institutional and individual customers through approximately 150 electronic exchanges and market centers. Interactive Brokers Group, Inc. was founded in 1977 and is headquartered in Greenwich, Connecticut.

Sales Growth

Interactive Brokers Group’s sales growth is 36% for the ongoing quarter and 43.3% for the next.

More news about Interactive Brokers Group.

7. Bristol (BMY)

Shares of Bristol jumped 6.29% in from $74.46 to $79.14 at 18:21 EST on Thursday, after two successive sessions in a row of gains. NYSE is jumping 0.41% to $15,545.52, after two successive sessions in a row of gains.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

Moving Average

Bristol’s value is way above its 50-day moving average of $71.43 and above its 200-day moving average of $72.59.

Yearly Top and Bottom Value

Bristol’s stock is valued at $79.14 at 18:21 EST, below its 52-week high of $80.59 and way higher than its 52-week low of $53.22.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Bristol’s stock is considered to be oversold (<=20).

More news about Bristol.

8. Gilead Sciences (GILD)

Shares of Gilead Sciences rose by a staggering 20.38% in from $70.96 to $85.42 at 18:21 EST on Thursday, after three successive sessions in a row of gains. NASDAQ is rising 0.99% to $11,285.32, after two consecutive sessions in a row of gains.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

More news about Gilead Sciences.

9. The Travelers Companies (TRV)

Shares of The Travelers Companies jumped 6.43% in from $176.65 to $188.01 at 18:21 EST on Thursday, after five consecutive sessions in a row of gains. NYSE is rising 0.41% to $15,545.52, after two consecutive sessions in a row of gains.

The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United states and internationally. The company operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance. The Business Insurance segment offers workers' compensation, commercial automobile and property, general liability, commercial multi-peril, employers' liability, public and product liability, professional indemnity, marine, aviation, onshore and offshore energy, construction, terrorism, personal accident, and kidnap and ransom insurance products. This segment operates through select accounts, which serve small businesses; commercial accounts that serve mid-sized businesses; national accounts, which serve large companies; and national property and other that serve large and mid-sized customers, commercial trucking industry, and agricultural businesses, as well as markets and distributes its products through brokers, wholesale agents, and program managers. The Bond & Specialty Insurance segment provides surety, fidelity, management and professional liability, and other property and casualty coverages and related risk management services through independent agencies and brokers. The Personal Insurance segment offers property and casualty insurance covering personal risks, primarily automobile and homeowners insurance to individuals through independent agencies and brokers. The Travelers Companies, Inc. was founded in 1853 and is based in New York, New York.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.7%, now sitting on 36.26B for the twelve trailing months.

More news about The Travelers Companies.

10. Fifth Third Bancorp (FITBI)

Shares of Fifth Third Bancorp rose 1.95% in from $25.14 to $25.63 at 18:21 EST on Thursday, after four sequential sessions in a row of gains. NASDAQ is rising 0.99% to $11,285.32, after two successive sessions in a row of gains.

Fifth Third is a bank that's as long on innovation as it is on history. Since 1858, we've been helping individuals, families, businesses and communities grow through smart financial services that improve lives. Our list of firsts is extensive, and it's one that continues to expand as we explore the intersection of tech-driven innovation, dedicated people, and focused community impact. Fifth Third is one of the few U.S.-based banks to have been named among Ethisphere's World's Most Ethical Companies® for several years. With a commitment to taking care of our customers, employees, communities and shareholders, our goal is not only to be the nation's highest performing regional bank, but to be the bank people most value and trust. Fifth Third Bank, National Association is a federally chartered institution. Fifth Third Bancorp is the indirect parent company of Fifth Third Bank and its common stock is traded on the NASDAQ® Global Select Market under the symbol “FITB.” Investor information and press releases can be viewed at www.53.com.

More news about Fifth Third Bancorp.

11. AbbVie (ABBV)

Shares of AbbVie rose 4.33% in from $152.77 to $159.39 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is jumping 0.41% to $15,545.52, after two sequential sessions in a row of gains.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 26.1% and 21.8%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 57.35B for the twelve trailing months.

Yearly Top and Bottom Value

AbbVie’s stock is valued at $159.39 at 18:21 EST, under its 52-week high of $175.91 and way higher than its 52-week low of $115.01.

Sales Growth

AbbVie’s sales growth for the next quarter is 6%.

More news about AbbVie.

12. Zoetis (ZTS)

Shares of Zoetis slid 0.73% in from $151.58 to $150.47 at 18:21 EST on Thursday, after five successive sessions in a row of gains. NYSE is rising 0.41% to $15,545.52, after two consecutive sessions in a row of gains.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zoetis’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 6.1%, now sitting on 7.89B for the twelve trailing months.

Moving Average

Zoetis’s worth is below its 50-day moving average of $152.16 and way under its 200-day moving average of $173.10.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 2.5% and 4.8%, respectively.

More news about Zoetis.

13. Chubb Corporation (CB)

Shares of Chubb Corporation rose 4.71% in from $204.52 to $214.15 at 18:21 EST on Thursday, after five successive sessions in a row of gains. NYSE is jumping 0.41% to $15,545.52, after two sequential sessions in a row of gains.

Chubb Limited provides insurance and reinsurance products worldwide. The company's North America Commercial P&C Insurance segment offers commercial property, casualty, workers' compensation, package policies, risk management, financial lines, marine, construction, environmental, medical, cyber risk, surety, and excess casualty; and group accident and health insurance to large, middle market, and small commercial businesses. Its North America Personal P&C Insurance segment provides affluent and high net worth individuals and families with homeowners, automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The company's North America Agricultural Insurance segment offers multiple peril crop and crop-hail insurance; and coverage for farm and ranch property, and commercial agriculture products. Its Overseas General Insurance segment provides coverage for traditional commercial property and casualty; specialty categories, such as financial lines, marine, energy, aviation, political risk, and construction risk; and group accident and health, and traditional and specialty personal lines for corporations, middle markets, and small customers through retail brokers, agents, and other channels. The company's Global Reinsurance segment offers traditional and specialty reinsurance under the Chubb Tempest Re brand to property and casualty companies. Its Life Insurance segment provides protection and savings products comprising whole life, endowment plans, individual term life, group term life, medical and health, personal accident, credit life, universal life, and unit linked contracts. The company markets its products primarily through insurance and reinsurance brokers. The company was formerly known as ACE Limited and changed its name to Chubb Limited in January 2016. Chubb Limited was incorporated in 1985 and is headquartered in Zurich, Switzerland.

More news about Chubb Corporation.

14. Cardinal Health (CAH)

Shares of Cardinal Health jumped 4.59% in from $75 to $78.44 at 18:21 EST on Thursday, following the last session’s downward trend. NYSE is rising 0.41% to $15,545.52, after two consecutive sessions in a row of gains.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 181.36B for the twelve trailing months.

Volatility

Cardinal Health’s last week, last month’s, and last quarter’s current intraday variation average was 1.13%, 0.30%, and 1.42%.

Cardinal Health’s highest amplitude of average volatility was 1.13% (last week), 1.41% (last month), and 1.42% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 25.6% and a negative 2.4%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Cardinal Health’s stock is considered to be oversold (<=20).

More news about Cardinal Health.

15. Astrazeneca (AZN)

Shares of Astrazeneca jumped by a staggering 13.98% in from $58.01 to $66.12 at 18:21 EST on Thursday, after five successive sessions in a row of gains. NYSE is jumping 0.41% to $15,545.52, after two successive sessions in a row of gains.

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Revenue Growth

Year-on-year quarterly revenue growth grew by 31%, now sitting on 44.04B for the twelve trailing months.

Volatility

Astrazeneca’s last week, last month’s, and last quarter’s current intraday variation average was 0.58%, 0.84%, and 1.41%.

Astrazeneca’s highest amplitude of average volatility was 0.70% (last week), 1.34% (last month), and 1.41% (last quarter).

More news about Astrazeneca.

16. Broadridge Financial Solutions (BR)

Shares of Broadridge Financial Solutions rose 2.7% in from $144.53 to $148.43 at 18:21 EST on Thursday, after five sequential sessions in a row of gains. NYSE is rising 0.41% to $15,545.52, after two successive sessions in a row of gains.

Broadridge Financial Solutions, Inc. provides investor communications and technology-driven solutions for the financial services industry. The company's Investor Communication Solutions segment processes and distributes proxy materials to investors in equity securities and mutual funds, as well as facilitates related vote processing services; and distributes regulatory reports, class action, and corporate action/reorganization event information, as well as tax reporting solutions. It also offers ProxyEdge, an electronic proxy delivery and voting solution; data-driven solutions and an end-to-end platform for content management, composition, and omni-channel distribution of regulatory, marketing, and transactional information, as well as mutual fund trade processing services; data and analytics solutions; solutions for public corporations and mutual funds; SEC filing and capital markets transaction services; registrar, stock transfer, and record-keeping services; and omni-channel customer communications solutions, as well as operates Broadridge Communications Cloud platform that creates, delivers, and manages communications and customer engagement activities. The company's Global Technology and Operations segment provides solutions that automate the front-to-back transaction lifecycle of equity, mutual fund, fixed income, foreign exchange and exchange-traded derivatives, order capture and execution, trade confirmation, margin, cash management, clearance and settlement, reference data management, reconciliations, securities financing and collateral management, asset servicing, compliance and regulatory reporting, portfolio accounting, and custody-related services. This segment also offers business process outsourcing services; technology solutions, such portfolio management, compliance, fee billing, and operational support solutions; and capital market and wealth management solutions. The company was founded in 1962 and is headquartered in Lake Success, New York.

More news about Broadridge Financial Solutions.

17. Nasdaq Inc (NDAQ)

Shares of Nasdaq Inc jumped by a staggering 11.6% in from $60.15 to $67.13 at 18:21 EST on Thursday, after four successive sessions in a row of gains. NASDAQ is jumping 0.99% to $11,285.32, after two consecutive sessions in a row of gains.

Nasdaq, Inc. is a technology company which serves capital markets worldwide. Market Technology includes the anti-financial crimes technology business. This segment offers Nasdaq Trade Surveillance (a SaaS platform for market participants and brokers to help them comply with internal and external market regulations and rules); Nasdaq Automated Inspector, a cloud-deployed tool that detects money laundering; and Verafin which is a SaaS provider of solutions for managing anti-financial criminal activity. The segment handles cash, equity derivatives and currencies. It also deals with assets such as digital currencies, currency, interest-bearing security, commodities, energy products, or currencies. Investment Intelligence sells and distributes historic and current market data, develops and licenses Nasdaq financial indexes and products and offers investment insight and workflow solutions. Corporate Platforms provides investor relations and governance advice. It had 4,178 listed securities as of December 31, 2021. This includes 1,632 on the Nasdaq Global Select Market and 1,169 listings on the Nasdaq Global Market. There were also 1,169 listings on Nasdaq Capital Market. Market Services includes trading in equity derivatives and clearing, clearing cash equity trading, commodity trading and clearing and trading management services. The Market Services segment manages various marketplaces across different asset classes. It includes derivatives, cash, commodity, structured products and exchange traded products. This group also provides clearing, settlement and broker services. The company used to be known as The NASDAQ OMX Group, Inc., but changed its name in September 2015 to Nasdaq, Inc. Nasdaq, Inc. is an American company that was established in 1971. Its headquarters are located in New York, New York.

Annual Top and Bottom Value

Nasdaq Inc stock was valued at $67.13 as of 18:21 EST. This is lower than the 52-week high $70.55 but much higher that its low 52-week of $46.77.

Revenue growth

The year-on-year revenue growth was 14.7%. We now have 6.11B in the 12 trailing months.

More news about Nasdaq Inc.

18. Rogers Communication (RCI)

Shares of Rogers Communication jumped 7.83% in from $41.75 to $45.02 at 18:21 EST on Thursday, after four successive sessions in a row of gains. NYSE is rising 0.41% to $15,545.52, after two consecutive sessions in a row of gains.

Rogers Communications Inc. is a Canadian communications and media company. The company operates in three areas: Wireless, Cable, and Media. It offers wireless Internet access, voice and enhanced voice, accessory and device financing, mobile Internet, wired voice and wireless voice, home phone and device protection, wireless device, global voice, data roaming and bridging landline. The company also offers Internet and WiFi services and smart home monitoring services. These include monitoring, security and automation as well as energy efficiency and smart control via a smartphone application. The company also offers on-demand and local TV, cloud-based digital video recorders, voice-activated remote control, and integrated apps, personal video recorders, linear and time-shifted programming, digital specialty channels, 4K TV programming, and televised content for smartphones, tablets, or personal computers. It also operates Ignite TV, Ignite TV App, and Ignite TV. It also offers residential and small-business local telephony services. It also holds the Toronto Blue Jays team and Rogers Centre venue. The company operates Sportsnet ONE and Sportsnet 360 television networks. OLN radio stations, 55 AM and FM radio stations, and Sportsnet 360. It was established in Canada in 1960.

Volatility

Rogers Communication’s last week, last month’s, and last quarter’s current intraday variation average was 1.03%, 0.74%, and 1.37%.

Rogers Communication’s highest amplitude of average volatility was 1.28% (last week), 1.34% (last month), and 1.37% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 8%, now sitting on 15.07B for the twelve trailing months.

Annual Top and Bottom Value

Rogers Communication stock was valued at $45.02 as of 18:21 EST. This is way lower than the 52-week high at $64.55 but much higher than the 52-week low at $36.23.

More news about Rogers Communication.

19. Waste Connections (WCN)

Shares of Waste Connections rose 7.08% in from $132.59 to $141.98 at 18:21 EST on Thursday, after five successive sessions in a row of gains. NYSE is jumping 0.41% to $15,545.52, after two successive sessions in a row of gains.

Waste Connections, Inc. provides non-hazardous waste collection, transfer, disposal, and resource recovery services in the United States and Canada. It offers collection services to residential, commercial, municipal, industrial, and exploration and production (E&P) customers; landfill disposal services; and recycling services for various recyclable materials, including compost, cardboard, mixed paper, plastic containers, glass bottles, and ferrous and aluminum metals. The company also owns and operates transfer stations that receive compact and/or load waste to be transported to landfills or treatment facilities through truck, rail, or barge; and intermodal services for the rail haul movement of cargo and solid waste containers in the Pacific Northwest through a network of intermodal facilities. In addition, it provides E&P waste treatment, recovery, and disposal services for waste resulting from oil and natural gas exploration and production activity, such as drilling fluids, drill cuttings, completion fluids, and flowback water; production wastes and produced water during a well's operating life; contaminated soils that require treatment during site reclamation; and substances, which require clean-up after a spill, reserve pit clean-up, or pipeline rupture. Further, the company offers leasing services to its customers. As of December 31, 2021, it owned 334 solid waste collection operations; 142 transfer stations; 61 municipal solid waste (MSW) landfills; 12 E&P waste landfills; 14 non-MSW landfills; 71 recycling operations; 4 intermodal operations; 23 E&P liquid waste injection wells; and 19 E&P waste treatment and oil recovery facilities. The company also operates an additional 53 transfer stations, 10 MSW landfills, and 2 intermodal operations. Waste Connections, Inc. was founded in 1997 and is based in Woodbridge, Canada.

Yearly Top and Bottom Value

Waste Connections’s stock is valued at $141.98 at 18:22 EST, under its 52-week high of $148.20 and way higher than its 52-week low of $113.50.

More news about Waste Connections.

20. TJX Companies (TJX)

Shares of TJX Companies jumped by a staggering 13.53% in from $70.94 to $80.54 at 18:21 EST on Thursday, after five sequential sessions in a row of gains. NYSE is rising 0.41% to $15,545.52, after two sequential sessions in a row of gains.

The TJX Companies, Inc., together with its subsidiaries, operates as an off-price apparel and home fashions retailer. It operates through four segments: Marmaxx, HomeGoods, TJX Canada, and TJX International. The company sells family apparel, including footwear and accessories; home fashions, such as home basics, furniture, rugs, lighting products, giftware, soft home products, decorative accessories, tabletop, and cookware, as well as expanded pet, kids, and gourmet food departments; jewelry and accessories; and other merchandise. As of February 23, 2022, it operated 1,284 T.J. Maxx, 1,148 Marshalls, 850 HomeGoods, 59 Sierra, and 39 Homesense stores, as well as tjmaxx.com, marshalls.com, and sierra.com in the United States; 293 Winners, 147 HomeSense, and 106 Marshalls stores in Canada; 618 T.K. Maxx and 77 Homesense stores, as well as tkmaxx.com in Europe; and 68 T.K. Maxx stores in Australia. The company was incorporated in 1962 and is headquartered in Framingham, Massachusetts.

Volatility

TJX Companies’s last week, last month’s, and last quarter’s current intraday variation average was 1.36%, 0.64%, and 1.54%.

TJX Companies’s highest amplitude of average volatility was 2.24% (last week), 1.50% (last month), and 1.54% (last quarter).

Moving Average

TJX Companies’s value is much higher than its $50-day moving mean of $65.52 or its $200-day moving median of $63.33.

More news about TJX Companies.

21. Johnson & Johnson (JNJ)

Shares of Johnson & Johnson jumped 2.73% in from $172.31 to $177.01 at 18:21 EST on Thursday, after two consecutive sessions in a row of gains. NYSE is rising 0.41% to $15,545.52, after two sequential sessions in a row of gains.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Volatility

Johnson & Johnson’s last week, last month’s, and last quarter’s current intraday variation average was 0.73%, 0.18%, and 0.89%.

Johnson & Johnson’s highest amplitude of average volatility was 0.73% (last week), 0.84% (last month), and 0.89% (last quarter).

Moving Average

Johnson & Johnson’s value is above its 50-day moving average of $167.84 and higher than its 200-day moving average of $172.18.

More news about Johnson & Johnson.

22. Royalty Pharma (RPRX)

Shares of Royalty Pharma jumped 1.73% in from $42.2 to $42.93 at 18:21 EST on Thursday, following the last session’s downward trend. NASDAQ is jumping 0.99% to $11,285.32, after two successive sessions in a row of gains.

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Yearly Top and Bottom Value

Royalty Pharma’s stock is valued at $42.93 at 18:22 EST, below its 52-week high of $44.75 and way higher than its 52-week low of $36.15.

Revenue growth

The year-on-year revenue growth fell by 3.4%. We now have 2.26B in the 12 trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Royalty Pharma’s stock is considered to be overbought (>=80).

More news about Royalty Pharma.

23. Sempra Energy (SRE)

Shares of Sempra Energy rose by a staggering 10.66% in from $147.3 to $163.00 at 18:21 EST on Thursday, after five successive sessions in a row of gains. NYSE is jumping 0.41% to $15,545.52, after two successive sessions in a row of gains.

Sempra is an energy-services holding firm in the United States as well as internationally. Segment San Diego Gas & Electric Company provides electricity services and natural gas. The company offers natural gas services and electric services for approximately 3.3 million people. It covers approximately 4,100 miles. The Southern California Gas Company segment is responsible for operating a natural-gas distribution, transmission and storage system. This supplies natural gas to approximately 22 million people, covering 24,000 miles. Sempra Texas Utilities, a company segment, is involved in the regulation of electric transmission and distribution. It serves 3.8 million households and businesses and operates 140,000 miles worth of transmission and delivery lines. The transmission network includes 18249 circuit miles and 1,174 distribution and transmission substations. It also interconnects to 130 third-party generators totaling 45.403 megawatts. Sempra Energy was the company’s former name. In July 2021, it changed its name from Sempra Energy to Sempra. Sempra was established in 1998. Its headquarters are in San Diego, California.

Yearly Top and Bottom Value

Sempra Energy’s stock is valued at $163.00 at 18:22 EST, under its 52-week high of $176.47 and way above its 52-week low of $119.56.

Sales Growth

Sempra Energy has a sales growth of 11.7% in the current quarter, and 0.3% the following.

Volatility

The current intraday variation of Sempra Energy’s week-end, month-end, and quarter averages was 0.52% and 0.47% respectively.

Sempra Energy had the highest average volatility amplitude at 1.96%, 1.38% and 1.53% respectively.

More news about Sempra Energy.

24. NewMarket (NEU)

Shares of NewMarket jumped 5.75% in from $297.59 to $314.70 at 18:21 EST on Thursday, after three sequential sessions in a row of gains. NYSE is rising 0.41% to $15,545.52, after two successive sessions in a row of gains.

Through its subsidiaries, NewMarket Corporation is involved in the business of petroleum additives. It offers various lubricant products that can be used in vehicle and industrial applications. These include transmission fluids and offroad powertrain and hydraulic system fluids as well as gear oils and hydraulic oils. The company also offers fuel additives which are used in oil refinement and to improve the performance of petrol, diesel, and biofuels. The company also engages in antiknock compound business and contracts manufacturing and service activities. It owns and maintains real estate in Virginia. The company operates across North America, Latin America and the Asia Pacific. It also has operations in Europe, Asia Pacific, Europe Middle East, Africa, India, and Latin America. NewMarket Corporation was established in 1887. It is located in Richmond, Virginia.

Sales Growth

NewMarket’s sales growth for the next quarter is 2.9%.

More news about NewMarket.

25. Etsy (ETSY)

Shares of Etsy jumped by a staggering 17.76% in from $101.89 to $119.99 at 18:21 EST on Thursday, after three successive sessions in a row of gains. NASDAQ is rising 0.99% to $11,285.32, after two sequential sessions in a row of gains.

Etsy, Inc. operates two-sided online marketplaces that connect buyers and sellers primarily in the United States, the United Kingdom, Germany, Canada, Australia, France, and India. Its primary marketplace is Etsy.com that connects artisans and entrepreneurs with various consumers. The company also offers Reverb, a musical instrument marketplace; Depop, a fashion resale marketplace; and Elo7, a Brazil-based marketplace for handmade and unique items. In addition, it offers various seller services, including Etsy Payments, a payment processing service; Etsy Ads, an advertising platform; and Shipping Labels, which allows sellers in the United States, Canada, the United Kingdom, Australia, and India to purchase discounted shipping labels. Further, the company provides various seller tools, including Shop Manager dashboard, a centralized hub for Etsy sellers to track orders, manage inventory, view metrics and statistics, and have conversations with their customers; and Sell on Etsy, an application to enable enhanced onboarding and video uploading. Additionally, it offers Etsy seller analytics pages that provides insights regarding traffic acquisition for their shops; Targeted Offers, a sales and promotions tool, and social media tool; and accounting and bookkeeping services. The company also provides educational resources comprising blog posts, video tutorials, Etsy Seller Handbook, Etsy.com online forums, and insights; Etsy Teams, a platform to build personal relationships with other Etsy sellers; and a Star Seller program. As of December 31, 2021, it connected a total of 7.5 million active sellers to 96.3 million active buyers; and had 120 million items for sale. The company was formerly known as Indieco, Inc changed its name to Etsy, Inc. in June 2006. Etsy, Inc. was founded in 2005 and is headquartered in Brooklyn, New York.

More news about Etsy.

26. Horizon Therapeutics (HZNP)

Shares of Horizon Therapeutics rose by a staggering 19% in from $65.15 to $77.53 at 18:21 EST on Thursday, after four successive sessions in a row of gains. NASDAQ is rising 0.99% to $11,285.32, after two successive sessions in a row of gains.

Horizon Therapeutics Public Limited Company is a biotech company that focuses on developing, commercializing, and distributing medicines to people with rare and autoimmune diseases and severe inflammations. It operates two distinct segments: Orphan and Inflammation. The company’s product portfolio includes 12 medications in areas such as gout and ophthalmology. The company markets the intravenous injections TEPEZZA (teprotumumab trbw); KRYSTEXA (pegloticase infusion) and RAVICTI(glycerol penylbutyrate). It also sells PROCYSBI and BUPHENYL tablets for oral and subcutaneous use, and QUINSAIR (levofloxacin); and UPLIZNA injections for intravenous usage. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. The company has agreements to collaborate with HemoShear Therapeutics, LLC. The company is affiliated with HemoShear Therapeutics, LLC, Alpine Immune Sciences, Inc., Halozyme Therapeutics, Inc., and Arrowhead Pharmaceuticals, Inc. The former name of the company was Horizon Pharma Public Limited Company. In May 2019, Horizon Therapeutics Public Limited Company took over. Horizon Therapeutics Public Limited Company was established in 2005. It is located in Dublin, Ireland. Additional offices are in Deerfield, Illinois, Chicago, Illinois, Lake Forest, Illinois, South San Francisco, California, Washington, D.C., Gaithersburg, Maryland, Rockville, Maryland, and Mannheim, Germany.

Volatility

Horizon Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 0.22%, 0.79%, and 1.93%.

Horizon Therapeutics’s highest amplitude of average volatility was 0.84% (last week), 2.31% (last month), and 1.93% (last quarter).

Yearly Top and Bottom Value

Horizon Therapeutics’s stock is valued at $77.53 at 18:23 EST, way under its 52-week high of $117.49 and way above its 52-week low of $57.84.

Sales Growth

Horizon Therapeutics saw a negative 9.3% sales increase in the current quarter, and a negative 9.6% growth for the next.

More news about Horizon Therapeutics.

27. Bank of New York Mellon (BK)

Shares of Bank of New York Mellon jumped 9.96% in from $41.37 to $45.49 at 18:21 EST on Thursday, after five sequential sessions in a row of gains. NYSE is rising 0.41% to $15,545.52, after two sequential sessions in a row of gains.

The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally. The company operates through Securities Services, Market and Wealth Services, Investment and Wealth Management, and Other segments. The Securities Services segment offers custody, trust and depositary, accounting, exchange-traded funds, middle-office solutions, transfer agency, services for private equity and real estate funds, foreign exchange, securities lending, liquidity/lending services, prime brokerage, and data analytics. This segment also provides trustee, paying agency, fiduciary, escrow and other financial, issuer, and support services for brokers and investors. The Market and Wealth Services segment offers clearing and custody, investment, wealth and retirement solutions, technology and enterprise data management, trading, and prime brokerage services; and clearance and collateral management services. This segment also provides integrated cash management solutions, including payments, foreign exchange, liquidity management, receivables processing and payables management, and trade finance and processing services. The Investment and Wealth Management segment offers investment management strategies and distribution of investment products, investment management, custody, wealth and estate planning, private banking, investment, and information management services. The Other segment engages in the provision of leasing, corporate treasury, derivative and other trading, corporate and bank-owned life insurance, renewable energy investment, and business exit services. It serves central banks and sovereigns, financial institutions, asset managers, insurance companies, corporations, local authorities and high net-worth individuals, and family offices. The company was founded in 1784 and is headquartered in New York, New York.

More news about Bank of New York Mellon.

28. Southwestern Energy (SWN)

Shares of Southwestern Energy rose 9.23% in from $6.61 to $7.22 at 18:21 EST on Thursday, after five successive sessions in a row of gains. NYSE is jumping 0.41% to $15,545.52, after two consecutive sessions in a row of gains.

Southwestern Energy Company is an independent energy company that specializes in exploration, development and production of natural and oil in the United States. The company operates in two distinct segments: Exploration and Production and Marketing. It focuses its efforts on unconventional natural gas development and the discovery of oil reserves in Pennsylvania, West Virginia and Ohio. It had 768,050 acres of Appalachia, a total 1,527 wells under production, and approximately 21148 billion cubic feet (Bcfe) of proven natural gas, oil and NGLs resources. The company also deals in transportation and marketing of oil, natural gas and NGLs. It serves LNG exporters and energy companies as well as utilities and industrial buyers of natural gas. Southwestern Energy Company was founded in 1929. It is located in Spring, Texas.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Southwestern Energy’s stock is considered to be oversold (<=20).

Moving Average

Southwestern Energy’s value exceeds its 50-day moving mean of $6.81, and its 200-day moving mean of $6.84.

More news about Southwestern Energy.

29. Super Micro Computer (SMCI)

Shares of Super Micro Computer rose by a staggering 38.02% in from $66.09 to $91.22 at 18:21 EST on Thursday, after two sequential sessions in a row of gains. NASDAQ is rising 0.99% to $11,285.32, after two successive sessions in a row of gains.

Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high-performance server and storage solutions based on modular and open architecture. Its solutions range from complete server, storage, modular blade servers, blades, workstations, full racks, networking devices, server management software, and server sub-systems, as well as security software. The company also provides application-optimized server solutions, including rackmount and blade servers, storage systems, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company primarily operates in the United States, Europe, Asia, and internationally. Super Micro Computer, Inc. was incorporated in 1993 and is headquartered in San Jose, California.

Growth Estimates Quarters

For the current quarter, the company expects to grow by 337.9% and 15% respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 53%, now sitting on 5.2B for the twelve trailing months.

Volatility

Super Micro Computer’s intraday variation average for the week and quarter ended last week was negative 0.88%. It was positive 1.19% and positive 3.27%.

Super Micro Computer had the highest average volatility amplitude at 3.83%, 3.44% and 3.27% respectively.

More news about Super Micro Computer.

30. Zebra Technologies (ZBRA)

Shares of Zebra Technologies fell 0.96% in from $273.28 to $270.66 at 18:21 EST on Thursday, after four successive sessions in a row of gains. NASDAQ is rising 0.99% to $11,285.32, after two successive sessions in a row of gains.

Zebra Technologies Corporation and its subsidiaries provide enterprise asset intelligence solutions for the automated identification and data capture industry. The company operates in two distinct segments: Asset Intelligence & Tracking, and Enterprise Visibility & Mobility. The company designs, manufactures, and sells printers, which produce labels, wristbands, tickets, receipts, and plastic cards; dye-sublimination thermal card printers, which produce images which are used for personal identification, access control, and financial transactions; RFID printers that encode data into passive RFID transponders; accessories and options for our printers, including vehicle mounts and battery chargers; stock and customized thermal labels, receipts, ribbons, plastic cards, and RFID tags for printers; and temperature-monitoring labels primarily used in vaccine distribution. The company also offers technical and managerial support and repair; managed and professional services; real time location system and services; tags, sensors and exciters; middleware software and application software; physical inventory management and rugged tablets as well as enterprise-grade mobile computing products. The company also offers RFID readers, barcode scanners and image capture devices; workforce management solutions and workflow execution and task-management solutions as well as communication and collaboration options. The company also offers services such as maintenance, technical support and repair, managed, and professional services. It also has cloud-based subscriptions to software and robots automation solutions. Through its direct sales force and network partners, the company provides services to retail, e-commerce and manufacturing as well as transportation, logistics and healthcare. Lincolnshire, Illinois is the headquarters of the company.

Yearly Top and Bottom Value

Zebra Technologies’s stock is valued at $270.66 at 18:23 EST, way under its 52-week high of $615.00 and way above its 52-week low of $224.87.

Volatility

Zebra Technologies’s intraday variation average for the week and quarter ended last week was negative 0.45% and negative 0.33% respectively. It also stood at a positive 2.59 percent.

Zebra Technologies had the highest average volatility amplitude at 0.82%, 3.22% and 2.59% respectively.

More news about Zebra Technologies.